Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3091% below fair value
$0.61+0.07 (+13.38%)
Close on Nov 18, 2026Market cap $1.28MP/E –Yield –
Curis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Curis's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 108.7% from the year before. Over ten years it grew 26.7% a year on average. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +108.7% |
| FY2024 | Dec 31, 2024 | 0M | +19.1% |
| FY2023 | Dec 31, 2023 | 0M | +13.4% |
| FY2022 | Dec 31, 2022 | 0M | +2.0% |
| FY2021 | Dec 31, 2021 | 0M | +88.1% |
| FY2020 | Dec 31, 2020 | 0M | +46.7% |
| FY2019 | Dec 31, 2019 | 0M | +0.2% |
| FY2018 | Dec 31, 2018 | 0M | +11.0% |
| FY2017 | Dec 31, 2017 | 0M | +12.3% |
| FY2016 | Dec 31, 2016 | 0M | +7.6% |
| FY2015 | Dec 31, 2015 | 0M | +43.5% |
| FY2014 | Dec 31, 2014 | 0M | +4.4% |
| FY2013 | Dec 31, 2013 | 0M | +4.1% |
| FY2012 | Dec 31, 2012 | 0M | +3.5% |
| FY2011 | Dec 31, 2011 | 0M | +1.9% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2M | +238.2% |
| Q1 FY2026 | Mar 31, 2026 | 1M | +128.0% |
| Q4 FY2025 | Dec 31, 2025 | 1M | +105.4% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +163.9% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +117.1% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +46.9% |
| Q4 FY2024 | Dec 31, 2024 | 0M | +32.9% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +3.8% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +20.4% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +19.7% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +19.8% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +22.0% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +5.5% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +5.4% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +5.3% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +2.4% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +0.1% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +0.2% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +38.1% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +67.9% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +131.7% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +165.6% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +99.8% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +64.3% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +19.2% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +3.9% |
| Q4 FY2019 | Dec 31, 2019 | 0M | +0.3% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +0.1% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +0.1% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +0.3% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +1.0% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +13.2% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +15.2% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +16.4% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +16.6% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +10.9% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?